La Organización Mundial de la Salud (OMS) difundió hoy las primeras cifras de las dosis de las vacunas de Pfizer y AstraZeneca/Oxford que se están asignando a los países participantes del sistema internacional Covax. - LA NACION
Coronavirus: 2.2 million doses assigned to Argentina by Covax.
The World Health Organization (WHO) released today the first figures of the doses of the Pfizer and Oxford/AstraZeneca vaccines that are being assigned to the participating countries of the international Covax system.
In this first forecast, Argentina appears with 2,275,200 units assigned of the Oxford/AstraZeneca product for the first semester of the year, subject to the completion of the process of including the vaccine in the list of emergency use of the WHO. As indicated, this could happen in the next few days or weeks, according to the “latest reviews” in progress.
The document details a first allocation to 145 countries for the first two quarters with 240 million doses of the Oxford/AstraZeneca vaccine produced at the Serum Institute of India (SII) and another 96 million doses included in an agreement that is closing with the Gavi Alliance for Vaccines laboratory, which coordinates the Covax Initiative with the WHO and the Coalition for the Promotion of Innovations for Epidemic Preparedness (CEPI). The laboratory producing the doses initially planned for the country is SK Bioscience....
Last November, the Minister of Health of the Nation, Ginés González García, had announced the arrival of a greater number of doses through this access system: “We have already paid for 9 million vaccines through Covax that we would have available in the month of February ”, he had said.
The delay in the process of incorporation into the WHO emergency use list of the AstraZeneca vaccine, as explained last week by officials from the Pan American Health Organization (PAHO), is due to the fact that its production is decentralized. “When a product submitted for inclusion in the list of products for emergency use has been evaluated through other emergency mechanisms by a rigorous authority that shares its information with the prequalification program, WHO does not intend to duplicate the work ”, It was specified to LA NACION....
"We do not have the exact date for any country," said Jarbas Barbosa da Silva, PAHO's deputy director, this afternoon, regarding when the doses could begin to arrive in the region. In a press conference via Zoom, the official indicated that the availability of any vaccine through Covax depends on the producers meeting the conditions for WHO approval for emergency use. “The latest revisions are pending, which is the conclusion of the evaluation of the WHO prequalification team, for the AstraZeneca product and that process would be completed in two or three weeks.”, he added....